Detection of multivessel calcific disease progression in a patient with chronic limb-threatening ischemia using fluorine-18 sodium fluoride positron emission tomography imaging

Ting-Heng Chou, Molly K Wynveen, Eleanor T Rimmerman, Surina Patel, Michael R Go, Mitchel R Stacy, Ting-Heng Chou, Molly K Wynveen, Eleanor T Rimmerman, Surina Patel, Michael R Go, Mitchel R Stacy

Abstract

Vascular calcification contributes to morbidity and poor clinical outcomes for patients with peripheral artery disease; however, the traditional assessment of the calcium burden using computed tomography (CT) imaging or angiography represents already established disease. In the present report, we describe a 69-year-old man with chronic limb-threatening ischemia who had undergone positron emission tomography/CT imaging with fluorine-18 sodium fluoride to evaluate the relationship between baseline levels of positron emission tomography-detectable active vascular microcalcification and CT-detectable calcium progression 1.5 years later. CT imaging at follow-up identified progression of existing lesions and the formation of new calcium in multiple arteries that had demonstrated elevated fluorine-18 sodium fluoride uptake 1.5 years earlier.

Keywords: Calcification; Chronic limb-threatening ischemia; Diabetes mellitus; Positron emission tomography; Sodium fluoride.

© 2023 The Author(s).

Figures

Fig 1
Fig 1
Angiographic evaluation of the affected limb revealed significant disease in the anterior tibial and peroneal arteries (A) with occlusion of both arteries below the knee (B).
Fig 2
Fig 2
Fluorine-18 (18F)-sodium fluoride (NaF) positron emission tomography (PET)/computed tomography (CT) imaging of multivessel calcific disease progression. A, Baseline PET/CT imaging at study enrollment revealing various levels of CT-detectable calcium deposition in the popliteal, posterior tibial, anterior tibial, and peroneal arteries (white arrows) with active microcalcification occurring in multiple vessels, as shown by 18F-NaF PET imaging (white arrows). B, Follow-up CT imaging 1.5 years later demonstrating new calcium or progression of existing calcium within vascular regions (yellow arrows) that were previously identified as having elevated levels of 18F-NaF uptake (ie, active disease). SUV, Standardized uptake value.
Fig 3
Fig 3
Fluorine-18 (18F)-sodium fluoride (NaF) positron emission tomography (PET)/computed tomography (CT) imaging of popliteal artery disease progression. A, CT imaging at study enrollment revealing minimal calcium deposition in the popliteal artery. In contrast, PET imaging demonstrated diffuse uptake of 18F-NaF, indicating an active process of popliteal artery microcalcification. B, Follow-up CT imaging demonstrated new calcium deposition in the popliteal artery where 18F-NaF PET imaging had revealed active microcalcification 1.5 years earlier. SUV, Standardized uptake value.
Fig 4
Fig 4
Positron emission tomography (PET)/computed tomography (CT) imaging revealing minimal uptake of fluorine-18 (18F)-sodium fluoride (NaF) in a region of the popliteal artery at baseline (A) that corresponded to no change in the calcium mass score (B) at 1.5-year follow-up. SUV, Standardized uptake value.
Fig 5
Fig 5
Serial photographs of the patient's chronic diabetic foot wound during the 1.5-year study timeline. Evidence of prior reconstructive surgery is apparent, with slow, but progressive, healing of the wound.

References

    1. Huang C.L., Wu I.H., Wu Y.W., Hwang J.J., Wang S.S., Chen W.J., et al. Association of lower extremity arterial calcification with amputation and mortality in patients with symptomatic peripheral artery disease. PLoS One. 2014;9:e90201.
    1. Chowdhury M.M., Makris G.C., Tarkin J.M., Joshi F.R., Hayes P.D., Rudd J.H.F., et al. Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity. PLoS One. 2017;12:e0182952.
    1. Ohtake T., Oka M., Ikee R., Mochida Y., Ishioka K., Moriya H., et al. Impact of lower limbs’ arterial calcification on the prevalence and severity of PAD in patients on hemodialysis. J Vasc Surg. 2011;53:676–683.
    1. Guzman R.J., Brinkley D.M., Schumacher P.M., Donahue R.M.J., Beavers H., Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51:1967–1974.
    1. Stacy M.R. Radionuclide imaging of atherothrombotic diseases. Curr Cardiovasc Imaging Rep. 2019;12:17.
    1. Stacy M.R. Molecular imaging of lower extremity peripheral arterial disease: an emerging field in nuclear medicine. Front Med. 2022;8:793975.
    1. Takx R.A.P., van Asperen R., Bartstra J.W., Zwakenberg S.R., Wolterink J.M., Celeng C., et al. Determinants of 18F-NaF uptake in femoral arteries in patients with type 2 diabetes mellitus. J Nucl Cardiol. 2021;28:2700–2705.
    1. den Harder A.M., Wolterink J.M., Bartstra J.W., Spiering W., Zwakenberg S.R., Beulens J.W., et al. Vascular uptake on 18F-sodium fluoride positron emission tomography: precursor of vascular calcification? J Nucl Cardiol. 2021;28:2244–2254.
    1. Chou T.H., Rimmerman E.T., Patel S., Wynveen M.K., Eisert S.N., Musini K.N., et al. Vessel-by-vessel analysis of 18F-NaF PET/CT imaging quantifies diabetes- and chronic kidney disease-induced active microcalcification in patients with peripheral arterial disease. EJNMMI Res. 2023;13:3.
    1. Eisert S.N., Chou T.H., Bobbey A.J., Go M.R., Stacy M.R. Noninvasive detection of active microcalcification in an occlusive peripheral vascular aneurysm using 18F-NaF PET/CT imaging. Clin Nucl Med. 2020;45:1029–1031.
    1. Bellinge J.W., Francis R.J., Lee S.C., Phillips M., Rajwani A., Lewis J.R., et al. 18F-sodium fluoride positron emission tomography activity predicts the development of new coronary artery calcifications. Arter Thromb Vasc Biol. 2021;41:534–541.
    1. Fiz F., Piccardo A., Morbelli S., Bottoni G., Piana M., Cabria M., et al. Longitudinal analysis of atherosclerotic plaques evolution: an 18F-NaF PET/CT study. J Nucl Cardiol. 2022;29:1713–1723.

Source: PubMed

3
Subscribe